跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,460 条关于
“BCR/ABL1”
全部
2,460
临床试验
1,645
药物
488
机构
24
资讯
303
6个月前
Digital PCR Outperforms Standard RT-qPCR in Detecting Residual BCR::ABL1 in CML Patients, Enabling Better TKI Discontinuation Decisions
3年前
Asciminib Demonstrates Durable Efficacy and Safety in Heavily Pretreated CML-CP Patients
去年
FDA Approves Scemblix (asciminib) for First-Line Treatment of Chronic Myelogenous Leukemia
去年
Novartis Receives CDSCO Approval for Phase IIIb Trial of Asciminib in Chronic Myeloid Leukemia
去年
Enliven Therapeutics' ELVN-001 Shows Promising Phase 1 Data in Chronic Myeloid Leukemia
5个月前
Flumatinib Therapeutic Drug Monitoring Reveals Key Exposure Thresholds for Molecular Response in Chinese CML-CP Patients
2年前
Triplet Therapy Shows Promise in Advanced Chronic Myeloid Leukemia
去年
ImmunoForge's Pemziviptadil Receives FDA IND Approval for Phase 2 DMD Cardiomyopathy Trial
去年
SOHO 2024: Advancements in ALL, CML, and CLL Treatment Strategies
9个月前
Ascentage Pharma's Olverembatinib Shows 23.1% Response Rate in Rare GIST Subtype with Novel Lipid Metabolism Mechanism
第 1 页,共 31 页
上一页
下一页